10X Genomics Inc
NASDAQ:TXG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
T
|
Thomas Scott (India) Ltd
NSE:THOMASCOTT
|
IN |
|
I
|
IGS Capital Group Ltd
OTC:IGSC
|
MY |
|
U-Next Holdings Co Ltd
OTC:USNNF
|
JP |
|
A
|
Adocia SA
PAR:ADOC
|
FR |
|
C
|
Catalyst Bancorp Inc
NASDAQ:CLST
|
US |
Wall Street
Price Targets
TXG Price Targets Summary
10X Genomics Inc
According to Wall Street analysts, the average 1-year price target for
TXG
is 21.13 USD
with a low forecast of 17.17 USD and a high forecast of 26.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TXG's stock price target?
Price Target
21.13
USD
According to Wall Street analysts, the average 1-year price target for
TXG
is 21.13 USD
with a low forecast of 17.17 USD and a high forecast of 26.25 USD.
What is 10X Genomics Inc's Revenue forecast?
Projected CAGR
4%
For the last 7 years the
compound annual growth rate for
10X Genomics Inc's revenue is
24%.
The projected
CAGR
for the next 3 years is
4%.
